This inventor holds 1 USPTO granted patent. Top assignees: Chu De Bordeaux, National Institute of Health and Medical Research, Toyama Chemical Co., Ltd.. Active years: 2018.
Company Filing History:
1 out of 3 
1 out of 1,853 
1 out of 159 
Years Active: 2018
Title: Cédric Laouenan: Innovator in Ebola Treatment
Introduction
Cédric Laouenan is a notable inventor based in Paris, France. He has made significant contributions to the field of medicine, particularly in the treatment of Ebola Virus Disease. His innovative approach has led to the development of pharmaceutical compositions that aim to combat this deadly virus.
Latest Patents
Cédric Laouenan holds a patent for "Methods and pharmaceutical compositions for the treatment of Ebola virus disease." This invention focuses on a method of treating Ebola Virus Disease in a subject in need thereof, which involves administering a therapeutically effective amount of Favipiravir. This patent highlights his commitment to addressing critical health challenges.
Career Highlights
Throughout his career, Laouenan has worked with esteemed institutions such as the Institut National de la Santé et de la Recherche Médicale and the Université de Bordeaux. His work in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Some of his notable coworkers include Denis Malvy and Sylvain Baize. Their collective efforts have further advanced the understanding and treatment of infectious diseases.
Conclusion
Cédric Laouenan's contributions to the treatment of Ebola Virus Disease through his innovative patent demonstrate his dedication to improving global health. His work continues to inspire future research and development in the medical field.